Antibodies have become an integral part of research and medicine. Therapeutic applications of antibodies began to emerge following the publication of Köhler and Milstein’s groundbreaking 1975 paper in ...

MUNICH--(BUSINESS WIRE)--CatalYm today announced the presentation of the first preclinical data demonstrating that the company’s clinical-stage antibody visugromab can improve the anti-tumor activity ...

Antibody-based immune therapy could become a key weapon in the fight against bird flu after trials in monkeys successfully prevented severe illness and death from the infection. The preventative ...

Neutralizing Antibody Market is estimated to valued at USD 243.93 Bn in 2025 and expected reach USD 434.58 Bn by 2032, growing at CAGR of 8.6% from 2025 to 2032 BURLINGAME, CA, UNITED STATES, July 11, ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

Typically, an antibody-drug, an anti-idiotype antibody (anti-ID Ab, see the schematic image) attaches itself to the idiotype of another antibody. An idiotype is the particular arrangement of idiotopes ...